Search research articles
Contact Us
Filters
Showing results (151-160 of 164) with videos related to
Page
of 17
Sort By:
Lancet (London, England)
|
January 17, 1987
Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia
D D Ma, R D Scurr, R A Davey, et al.
Gynecologic Oncology
|
June 1, 1988
Cisplatin plus VP 16-213 in advanced ovarian carcinoma
P R Harnett, D R Bell, B L Hillcoat, et al.
Journal of Neuro-Oncology
|
January 5, 2002
Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme
G M Marx, N Pavlakis, S McCowatt, et al.
European Journal of Biochemistry
|
October 1, 1995
Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes
P S Jones, R Savory, P Barratt, et al.
Biochemical Society Transactions
|
May 1, 1996
The characterisation of expression of three murine peroxisome proliferator activated receptor genes
A R Bell, P S Jones, R Savory, et al.
Investigational New Drugs
|
March 11, 2006
Phase II study of vinflunine in patients with metastatic renal cell carcinoma
D Goldstein, S P Ackland, D R Bell, et al.
Gut
|
August 13, 2003
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer
L Jackson, W Wahli, L Michalik, et al.
The Journal of Biological Chemistry
|
March 29, 1996
Cloning and structure of delta-latroinsectotoxin, a novel insect-specific member of the latrotoxin family: functional expression requires C-terminal truncation
I E Dulubova, V G Krasnoperov, M V Khvotchev, et al.
The Biochemical Journal
|
August 15, 1993
Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs
D R Bell, N J Plant, C G Rider, et al.
The Medical Journal of Australia
|
May 19, 1997
Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy
M Michael, J F Bishop, J A Levi, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 164) with videos related to
Sort By:
Page
of 17
Lancet (London, England)
|
January 17, 1987
Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia
D D Ma, R D Scurr, R A Davey, et al.
Gynecologic Oncology
|
June 1, 1988
Cisplatin plus VP 16-213 in advanced ovarian carcinoma
P R Harnett, D R Bell, B L Hillcoat, et al.
Journal of Neuro-Oncology
|
January 5, 2002
Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme
G M Marx, N Pavlakis, S McCowatt, et al.
European Journal of Biochemistry
|
October 1, 1995
Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes
P S Jones, R Savory, P Barratt, et al.
Biochemical Society Transactions
|
May 1, 1996
The characterisation of expression of three murine peroxisome proliferator activated receptor genes
A R Bell, P S Jones, R Savory, et al.
Investigational New Drugs
|
March 11, 2006
Phase II study of vinflunine in patients with metastatic renal cell carcinoma
D Goldstein, S P Ackland, D R Bell, et al.
Gut
|
August 13, 2003
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer
L Jackson, W Wahli, L Michalik, et al.
The Journal of Biological Chemistry
|
March 29, 1996
Cloning and structure of delta-latroinsectotoxin, a novel insect-specific member of the latrotoxin family: functional expression requires C-terminal truncation
I E Dulubova, V G Krasnoperov, M V Khvotchev, et al.
The Biochemical Journal
|
August 15, 1993
Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs
D R Bell, N J Plant, C G Rider, et al.
The Medical Journal of Australia
|
May 19, 1997
Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy
M Michael, J F Bishop, J A Levi, et al.
Page
of 17